Southpoint Capital Advisors LP grew its stake in shares of Colfax Co. (NYSE:CFX) by 531.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,840,630 shares of the industrial products company’s stock after acquiring an additional 2,390,630 shares during the quarter. Colfax comprises approximately 2.1% of Southpoint Capital Advisors LP’s investment portfolio, making the stock its 22nd largest holding. Southpoint Capital Advisors LP owned about 2.09% of Colfax worth $124,448,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. FIL Ltd increased its holdings in Colfax by 117.2% in the 4th quarter. FIL Ltd now owns 267,696 shares of the industrial products company’s stock worth $10,237,000 after buying an additional 144,449 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Colfax in the 4th quarter worth approximately $1,243,000. Credit Suisse AG increased its holdings in Colfax by 27.1% in the 4th quarter. Credit Suisse AG now owns 103,550 shares of the industrial products company’s stock worth $3,959,000 after buying an additional 22,107 shares during the period. Public Employees Retirement System of Ohio increased its holdings in Colfax by 24.7% in the 4th quarter. Public Employees Retirement System of Ohio now owns 53,934 shares of the industrial products company’s stock worth $2,062,000 after buying an additional 10,681 shares during the period. Finally, Stifel Financial Corp increased its holdings in Colfax by 18.0% in the 4th quarter. Stifel Financial Corp now owns 68,383 shares of the industrial products company’s stock worth $2,615,000 after buying an additional 10,416 shares during the period. Hedge funds and other institutional investors own 96.34% of the company’s stock.
In other Colfax news, SVP Patricia A. Lang sold 24,677 shares of the firm’s stock in a transaction on Monday, May 3rd. The stock was sold at an average price of $43.94, for a total value of $1,084,307.38. Following the transaction, the senior vice president now owns 43,218 shares in the company, valued at approximately $1,898,998.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Matthew L. Trerotola sold 200,000 shares of the firm’s stock in a transaction on Friday, May 14th. The shares were sold at an average price of $43.14, for a total value of $8,628,000.00. Following the completion of the transaction, the chief executive officer now owns 505,708 shares in the company, valued at approximately $21,816,243.12. The disclosure for this sale can be found here. Insiders sold a total of 464,677 shares of company stock worth $20,374,157 in the last 90 days. 9.60% of the stock is currently owned by insiders.
Shares of NYSE:CFX traded down $0.36 during midday trading on Thursday, reaching $45.33. 6,948 shares of the company’s stock traded hands, compared to its average volume of 895,467. Colfax Co. has a 1 year low of $26.45 and a 1 year high of $50.26. The stock has a market cap of $6.15 billion, a P/E ratio of 111.44, a P/E/G ratio of 0.98 and a beta of 2.20. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.94 and a current ratio of 1.33. The company has a fifty day simple moving average of $45.07.
Colfax (NYSE:CFX) last announced its earnings results on Thursday, April 29th. The industrial products company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.05. Colfax had a return on equity of 5.49% and a net margin of 1.83%. The firm had revenue of $879.21 million for the quarter, compared to analyst estimates of $841.42 million. On average, sell-side analysts forecast that Colfax Co. will post 2.15 earnings per share for the current fiscal year.
Colfax Company Profile
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment.
Further Reading: Why do corrections happen?
Want to see what other hedge funds are holding CFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colfax Co. (NYSE:CFX).
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.